MARKET

Select Market Data Region

- EN
  
  Language
  
  ENGLISH THAI JAPANESE VIETNAMESE
- Sign in

FREE

One-click sign-up, free access to advanced features

Get personalized investment ideas from AI Coach, manage and analyze your own Portfolio & Watchlist, and receive dedicated support when you need account assistance.

Continue with Facebook

{{entry.stock}}
{{entry.security_name}}

{{user.social_name}}

Stock not found.

User not found.

July 1, 2026 02:18 AM finance.yahoo.com Positive

Neurocrine Biosciences' Ingrezza Momentum Seen Supporting 2026 Guidance Upgrade, UBS Says

NBIX

Neurocrine Biosciences' (NBIX) Ingrezza sales momentum could support a 2026 guidance increase, while

PREMIUM

Upgrade to read this MT Newswires article and get so much more.

A Silver or Gold subscription plan is required to access premium news articles.

Upgrade

Already have a subscription? Sign in

Read original source

Top Watch

US stock ideas Plan your wealth